DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.
Ota VK, Spíndola LN, Gadelha A, dos Santos Filho AF, Santoro ML, Christofolini DM, Bellucco FT, Ribeiro-dos-Santos ÂK, Santos S, Mari Jde J, Melaragno MI, Bressan RA, Smith Mde A, Belangero SI.
Ota VK, et al. Among authors: santos s.
Schizophr Res. 2012 Dec;142(1-3):206-8. doi: 10.1016/j.schres.2012.08.003. Epub 2012 Oct 1.
Schizophr Res. 2012.
PMID: 23036699